Insider · CIK 0001726896
David Polinsky
cfoofficerdirector
Files at ERNA (Ernexa Therapeutics Inc.), RFL (Rafael Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -2,027 | $2.03 | $4,105 | 297,084 | 19 d ago |
| Aug 31, 2026 | ERNA Ernexa Therapeutics Inc. | AGrant or award Stock Option (Right to buy)derivative | +5,083 | $0.00 | $0 | 5,083 | 41 d ago |
| Jun 21, 2025 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -2,347 | $1.60 | $3,743 | 268,075 | Jun 24, 2025 |
| May 29, 2025 | RFL Rafael Holdings, Inc. | XIn-the-money exercise Class B Common Stock, par value $.01 per share | +76,882 | $1.28 | $98k | 270,422 | May 30, 2025 |
| May 29, 2025 | RFL Rafael Holdings, Inc. | XIn-the-money exercise Class B Common Stockderivative | -76,882 | $0.00 | $0 | 0 | May 30, 2025 |
| Dec 21, 2024 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -2,002 | $1.84 | $3,674 | 145,918 | Dec 23, 2024 |
| Oct 25, 2024 | RFL Rafael Holdings, Inc. | FTax withholding Class B Common Stock, par value $.01 per share | -3,331 | $1.84 | $6,129 | 147,920 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.